Four fibres. Four sections. Full colon coverage. Only LYMA ID² does this

IMOfibe® (Isomaltooligosaccharide): 4,000mg PromOat® Oat Beta-Glucan: 3,000mg Chicory Inulin: 2,845mg Fructo-oligosaccharides (FOS):  1,200mg

Most gut supplements contain no prebiotics. LYMA ID² contains four - precisely chosen to feed every section of the colon.
Product image

Why do most probiotic supplements fail to deliver?

A probiotic without prebiotics means a gut supplement is not as effective as it could be. Probiotics are live bacteria - and live bacteria need food to survive. That food is prebiotic fibre. Without it, the bacteria arrive, find nothing to feed on and pass straight through.They can't colonise. They can't have an effect. Most probiotic supplements contain no prebiotics at all. .

What makes LYMA ID²'s prebiotic blend different?

Planting probiotics in a gut without prebiotics is like planting seeds in concrete. The seeds aren't the problem. It's the soil. LYMA ID² builds the soil. Four precisely chosen prebiotic fibres - IMOfibe®, PromOat®, Chicory Inulin and Fructo-oligosaccharides - each with a different chain length and molecular complexity, feeding every section of the colon from proximal to distal simultaneously. This is not partial coverage. This is full colon intelligence.

How do the four fibres work together?

Each fibre has a specific job in a specific location. IMOfibe® feeds the proximal colon. PromOat® targets mid-colon fermentation, and carries an independently authorised claim for maintaining normal cholesterol levels. Chicory Inulin feeds Bifidobacterium in the mid-colon. Fructo-oligosaccharides reach the distal colon for rapid fermentation coverage. Together they deliver 11,045mg of precisely targeted prebiotic fibre in every serving, creating the ideal environment for ActiBio®, the probiotic found in LYMA ID², to arrive, colonise and thrive. This is not a gut supplement. This is a system.

Things to Know
Things to Know

Most probiotic supplements contain no prebiotics at all - the bacteria arrive, find nothing to feed on and pass straight through

Prebiotic fibre is the food source that allows probiotic bacteria to colonise, thrive and have a lasting effect on the gut microbiome.

LYMA ID² contains four precisely chosen prebiotic fibres - each a different chain length, each feeding a different section of the colon

At 11,045mg per serving, LYMA ID² delivers one of the highest prebiotic fibre doses of any gut formula on the market

Prebiotic Fibre Blend in Detail

Clinical Dose

11,045mg total prebiotic fibre

Source

IMOfibe®, PromOat®, Chicory Inulin & Fructo-oligosaccharides

Organic Limits

The average gut supplement contains a single prebiotic fibre, feeding one section of the colon at best. Without full colon coverage, the majority of gut bacteria go unfed and probiotics pass straight through without colonising.

Technology

Four precisely chosen fibres of different chain lengths and molecular complexity, each targeting a specific section of the colon simultaneously, creating the ideal environment for ActiBio® to arrive, colonise and thrive

Region

Global

Data

Peer-reviewed prebiotic fibre trials

Your Questions About ID² Prebiotics

Each prebiotic fibre has a different chain length and molecular complexity, which determines where in the colon it is fermented. IMOfibe® feeds the proximal colon, PromOat® targets mid-colon fermentation, Chicory Inulin feeds Bifidobacterium in the mid-colon, and Fructo-oligosaccharides reach the distal colon. Using four fibres ensures every section of the colon receives targeted nourishment - full coverage, not partial.

Most probiotic supplements contain no prebiotics at all. Without prebiotic fibre as a food source, probiotic bacteria arrive in the gut, find nothing to feed on and pass straight through without establishing. The bacteria aren't the problem - it's the environment they arrive into. LYMA ID² provides 8.5g of multi-length prebiotic fibre, creating the conditions ActiBio® needs to function.

The average modern diet delivers less than 4g of prebiotic fibre daily - less than half of what LYMA ID² provides in a single serving. The world's longest-living populations consistently consume significantly higher quantities of diverse fibre. That gap - between what most people eat and what the gut actually needs - is a foundational part of what Professor Paul Clayton designed LYMA ID² to address.

References

1. Wang HF, Lim PS, Kao MD, et al. Current research on the role of isomaltooligosaccharides in gastrointestinal health and metabolic diseases. Journal of Food Science and Nutrition. 2024;29(3). https://pmc.ncbi.nlm.nih.gov/articles/PMC11223922/

2. de Morais Junior AC, Schincaglia RM, Viana RB, et al. The separate effects of whole oats and isolated beta-glucan on lipid profile: a systematic review and meta-analysis of randomised controlled trials. Clinical Nutrition ESPEN. 2023;53:224–237. https://pubmed.ncbi.nlm.nih.gov/36657917/

3. Gotteland M, Zazueta A, Pino JL, et al. Modulation of postprandial plasma concentrations of digestive hormones and gut microbiota by foods containing oat β-glucans in healthy volunteers. Foods. 2023;12(4):700. https://pmc.ncbi.nlm.nih.gov/articles/PMC9955387/

4. Deehan EC, Yang C, Perez-Muñoz ME, et al. Precision microbiome modulation with discrete dietary fiber structures directs short-chain fatty acid production. Cell Host & Microbe. 2020;27(3):389–404. https://pubmed.ncbi.nlm.nih.gov/32092297/

5. Joyce SA, Kamil A, Fleige L, Gahan CGM. The cholesterol-lowering effect of oats and oat beta glucan: modes of action and potential role of bile acids and the microbiome. Frontiers in Nutrition. 2019;6:171. https://pmc.ncbi.nlm.nih.gov/articles/PMC6892284/

6. Davani-Davari D, Negahdaripour M, Karimzadeh I, et al. Prebiotics: definition, types, sources, mechanisms, and clinical applications. Foods. 2019;8(3):92. https://pubmed.ncbi.nlm.nih.gov/30857316/

7. Baxter NT, Schmidt AW, Venkataraman A, et al. Dynamics of human gut microbiota and short-chain fatty acids in response to dietary interventions with three fermentable fibres. mBio. 2019;10(1):e02566-18. https://pubmed.ncbi.nlm.nih.gov/30696735/

From boundary breaking to personal triumphs...
Stories from the front line of LYMA.